《新股消息》貝特集團(01491.HK)上市延期 指需更多時間落實最終發售價等
家居必需品製造及銷售公司貝特集團控股(01491.HK)公布,由於需要更多時間落實關於最終發售價、國際配售的踴躍程度、香港公開發售的申請水平及香港發售股份的分配基準等資料的公告,以及取得監管機構的批准,故該公告的刊發及公司上市時間表將會延期。董事會將在切實可行的情況下盡快向市場提供最新資料。
據貝特集團早前曾公布,於10月30日至11月5日招股,招股價為1-1.2元,以每手2,000股計,入場費為2,424.18元。智富為獨家保薦人。股份於11月12日上市。是次共發行1.25億股股份,當中10%香港公開發售。按中位數計,公司預期集資淨額為8,610萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.